Workforce Banner 

  

Expanding the HIV Workforce: Trends and Innovative Approaches

 This CME certified webinar (0.75 AMA PRA Category 1 Credit(s)™)
was presented as a Learning Lab Session at IDWeek 2012, in San Diego CA.

            

Release date: January 17, 2013
Expiration date: January 31, 2014
Estimated time to complete activity: 0.75 hours

A PC or MAC with access to the Internet or an intent enabled mobile device is requited to access this CME certified webinar. 

Watch the video here (or click on the video link above) and download the presentation here

Jointly sponsored by

 
PIM2 and      HHlittle.

 

Target Audience 

This activity has been designed to meet the educational needs of physicians involved in the management of patients with HIV.

Program Overview

Health care reform being implemented across the country will provide healthcare insurance to approximately 32 million people currently uninsured in the United States. The majority of these newly insured, including a significant number of HIV positive people, will access their healthcare through community health centers (CHCs) and primary care providers. 


At the same time that significant numbers of newlly insured are entering into care, the HIV workforce continues to decrease. The aging of the HIV workforce presents significant challenges. An estimated 50 percent of the current HIV provider workforce is retiring in the next 5 to 10 years.Also, more people seeking HIV care will seek it outside of the traditional settings as Ryan White programs become more financially strained. At the same time, the Centers for Disease Control and the Health Resources and Services Administration's Bureau of Primary Healthcare are both emphasizing routine HIV screening as a part of routine primary care. This increase is coupled with the estimated 56,000 new infections each year.

Studies have shown that patients managed by experienced HIV physicians have significantly better treatment outcomes and receive more cost effective care. The current HIV workforce is largely made up of providers that responded to a need in the first days of the epidemic over 20 years ago and are now ready for retirement. While these providers are leaving, the number of people living with HIV continues to grow, with few new providers entering the field.

Providers must understand the trends and what approaches to remedying these trends that they can benefit from in terms of their current HIV practice and the future care provided to their patients and community.

Educational Objectives

After completing this activity, the participant should be better able to: 

Webinar Presentation Outline

The HIV Workforce Shortage: From Trends to Training
Presenter: Donna Sweet, MD, MACP, AAHIVS

Trends in the HIV workforce covered in this session includes:

Motivating Infectious Disease Specialists to Provide HIV Care: Capitalizing on Provider Interest

Presenters: Ken Mayer, MD, FACP, Wilbert Jordan, MD, MPH, AAHIVS 

Faculty

Donna Sweet, MD, MDCP, AAHIVS
Vice Chair, Board of Directors
Professor of Medicine, University of Kansas School of Medicine - Wichita

Ken Mayer, MD, FACP
Research Medical Director
Fenway Institute / Fenway Health

Wilbert Jordan, MD, MPH, AAHIVS
Medical Director
O.A.S.I.S. Clinic 

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity. 

Name of Faculty or Presenter and Reported Finaicial Relationship

Donna Sweet, MD, MDCP, AAHIVS
Consulting Fees: Pfizer
Fees for Non-CME Services: BMS, Gilead

Ken Mayer, MD, FACP
Research Grants: Merck, BMS

Wilbert Jordan, MD, MPH, AAHIVS
Consulting Fees: BMS, Gilead, Janssen
Fees for Non-CME Services: BMS, Janssen, Gilead
Contracted Research: BMS, Gilead


The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following HealthHIV planners and managers, Javier G. Salazar, and Julio J. Fonseca hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Method of Participation and Request for Credit

There are no fees for participating and receiving CME credit for this activity. During the period January 31, 2013 through December 31, 2013, participants must read the learning objectives and faculty disclosures and study the educational activity. 

How to Obtain Your CME Credit

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on CME University by following these steps:

1. Click on the "Find Post-Test/Evaluation by Course:" at the top of the page.
2. Type in "9251" and hit enter.
3. Click on the activity title when it appears
4. Choose your profession/type of credit you are seeking.
5. Complete the online Evaluation Form. Upon completion of the online Evaluation form, you will have immediate access to a certificate of attendance to print or save for your files. If you have any questions regarding the CE certification for this activity, please contact Postgraduate Institute for Medicine at: or (303) 799-1930.

Media

Internet 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM) and HealthHIV do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM and HealthHIV. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Click here to learn more about the HIV Workforce Capacity Building Initiative
. 

To learn about becoming a mentor or receiving free mentoring, contact or call 202-232-6749

 

Contact
For more information, contact or call 202-232-6749.
Funding for the HIV Workforce Capacity Building Initiative provided  through an unrestricted grant from Bristol-Myers Squibb.

 

 

Prepare to print

Share Our Site:

Get link code to this page